ArticleArchives of medical science : AMS2026
Facts and myths about the use and effects of statins in patients with dyslipidaemia: a survey of physicians.
Article in Archives of medical science : AMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Medication adherence in vascular prevention: findings from the SIFHON-ADH survey in Argentina.Archives of medical science : AMS · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Statins are the primary medications used to treat lipid disorders. However, numerous myths surrounding statin therapy lead to patient non-adherence and therapy discontinuation. The aim of this study was to assess the most common patient concerns regarding statin use. Material and methods: A survey was conducted targeting doctors using an online questionnaire The first section included questions regarding socio-economic status, while the second focused on patient experiences related to refusing statin treatment due to fears of specific side effects, encounters with side effects during therapy, and estimates of the percentage of patients who discontinue treatment. The concluding section addressed the most common reasons for treatment termination from the perspective of practitioners, along with efforts to educate their patients. Results: 260 questionnaires were collected. Notably, 84% and 81% of doctors reported encountering refusals of statin treatment due to patients' fears of liver and muscle damage, respectively. The majority of respondents indicated that 10-20% of patients discontinue treatment on their own, despite significant side effects occurring in less than 10% of cases. Muscular symptoms were cited as the reason for discontinuing therapy in 75% of cases, while misinformation regarding statin side effects contributed to 53% of discontinuations. Additionally, 96.5% of doctors reported making efforts to educate their patients about statins. Conclusions: Many harmful beliefs about the side effects of statins persist among patients, resulting in non-adherence to treatment. The most prevalent concerns involve fears related to muscle and liver damage. These issues can be mitigated through targeted education for both patients and healthcare professionals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.